Synergistic effect of tetrandrine and ethidium bromide against methicillin-resistant Staphylococcus aureus (MRSA)

Journal of Toxicological Sciences

Volumn 36, Issue 5, 2011, Pages 645-651

  Lee, Young Seob ^a   Han, Sin Hee ^a   Lee, Su Hwan ^a   Kim, Young Guk ^a   Park, Chung Berm ^a   Kang, Ok Hwa ^b   Keum, Joon Ho ^b   Kim, Sung Bae ^b   Mun, Su Hyun ^b   Shin, Dong Won ^c   Kwon, Dong Yeul ^b  

^a Rural Development Administration   (South Korea)

^b Wonkwang University   (South Korea)

^c Sunchon National University   (South Korea)

Author keywords

Antibacterial activity; Ethidium bromide; Staphylococcus aureus; Tetrandrine

Indexed keywords

ETHIDIUM BROMIDE; TETRANDRINE;

ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; EVALUATION; INCUBATION TIME; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 80053465791     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.36.645     Document Type: Letter

References (29)

1. Choi, J.G., Kang, O.H., Lee, Y.S., Oh, Y.C., Chae, H.S., Jang, H.J., Kim, J.H., Sohn, D.H., Shin, D.W., Park, H. and Kwon, D.Y. (2008): In vitro activity of methyl gallate isolated from Galla rhois alone and in combination with ciprofloxacin against clinical isolates of salmonella. J. Microbiol. Biotechnol., 18, 1848-1852.
2. Choi, J.G., Kang, O.H., Brice, O.O., Lee, Y.S., Chae, H.S., Oh, Y.C., Sohn, D.H., Park, H., Choi, H.G., Kim, S.G., Shin, D.W. and Kwon, D.Y. (2010): Antibacterial Activity of Ecklonia cava Against Methicillin-Resistant Staphylococcus aureus and Salmonella spp. Foodborne. Pathog. Dis., 7, 435-441.
3. DeMarco, C.E., Cushing, L.A., Frempong-Manso, E., Seo, S.M., Jaravaza, T.A.A. and Kaatz, G.W. (2007): Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents. Chemother., 51, 3235-3239.
4. Fang, D.C. and Jiang, M.X. (1986): Studies on tetrandrine calcium antagonistic action. Chin. Med. J. (Engl), 99, 638-644.
5. Fu, Y., Zu, Y., Chen, L., Shi, X., Wang, Z., Sun, S. and Efferth, T. (2007): Antimicrobial activity of clove and rosemary essential oils alone and in combination. Phytother. Res., 21, 989-994.
6. Gibbons, S. (2004): Anti-staphylococcal plant natural products. Nat. Prod. Rep., 21, 263-277.
7. Gibbons, S., Oluwatuyi, M. and Kaatz, G.W. (2003): A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J. Antimicrob. Chemother., 51, 13-17.
8. Huang, Y.T. and Hong, C.Y. (1998): Tetrandrine. Cardiovasc. Drug Rev., 16, 1-15.
9. Jarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., Nesme, X., Etienne J. and Vandenesch, F. (2002): Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (Alleles), and human disease. Infect. Immun., 70, 631-641.
10. Jung, H.J. and Lee, D.G. (2008): Synergistic antibacterial effect between silybin and N,N'-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates. J. Microbiol., 46, 462-467.
11. Kuroda, M., Nagasaki, S. and Ohta, T. (2007): Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother., 59, 425-432.
12. Lee, Y.S., Kang, O.H., Choi, J.G., Oh, Y.C., Chae, H.S., Kim, J.H., Park, H., Sohn, D.H., Wang, Z.T. and Kwon, D.Y. (2008): Synergistic effects of the combination of galangin with gentamicin against methicillin-resistant Staphylococcus aureus. J. Microbiol., 46, 283-288.
13. Levine, L. (2005): Tetrandrine and thapsigargin release arachidonic acid from cells in culture and stimulate prostacyclin production in rat liver cells, but may do so by different pathways. BMC Pharmacol., 24, 5-12.
14. Levy, S.B. (1992): Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother., 36, 695-703.
15. Levy, S.B. (2000): Antibiotic and antiseptic resistance: impact on public health. Pediatr. Infect. Dis. J., 19, S120-S122.
16. Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W.V. and Pages, J.M. (2007): Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. J. Antimicrob. Chemoth., 59, 1223-1229.
17. Markham, P.N. and Neyfakh, A.A. (2001): Efflux-mediated drug resistance in Gram-positive bacteria. Curr. Opin. Microbiol., 4, 509-514.
18. Mohtar, M., Johari, S.A., Li, A.R., Isa, M.M., Mustafa, S., Ali, A.M. and Basri, D.F. (2009): Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA). Curr. Microbiol., 59, 181-186.
19. Oluwatuyi, M., Kaatz, G.W. and Gibbons, S. (2004): Antibacteri- al and resistance modifying activity of Rosmarinus officinalis. Phytochemistry, 65, 3249-3254.
20. Poole, K. (2000): Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob. Agents Chemother., 44, 2233-2241.
21. Poole, K. (2004): Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infec., 10, 12-26.
22. Saiful, A.J., Mastura, M., Zarizal, S., Mazurah, M.I., Shuhaimi, M. and Ali, A.M. (2008): Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J. Basic Microbiol., 48, 245-251.
23. Sekiya, N., Hikiami, H., Yokoyama, K., Kouta, K., Sakakibara, I., Shimada, Y. and Terasawa K. (2005): Inhibitory effects of Stephania tetrandra S. Moore on free radical-induced lysis of rat red blood cells. Biol. Pharm. bull., 28, 667-670.
24. Stavri, M., Piddock, L.J.V. and Gibbons, S. (2007): Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother., 59, 1247-1260.
25. Sutter, M.C. and Wang, Y.X. (1993): Recent cardiovascular drugs from Chinese medicinal plants. Cardiovasc. Res., 27, 1891-1901.
26. Xie, Q.M., Tang, H.F., Chen, J.Q. and Bian, R.L. (2002): Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta. Pharmacol. Sin., 23, 1107-1113.
27. Xu, W.L., Shen, H.L., Ao, Z.F., Chen, B.A., Xia, W., Gao, F. and Zhang, Y.N. (2006): Combination of tetrandrine as a potentialreversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leuk. Res., 30, 407-413.
28. Yao, W.X. and Jiang, M.X. (2002): Effects of tetrandrine on cardiovascular electrophysiologic properties. Acta. Pharmacol. Sin., 23, 1069-1074.
29. Zhao, W.H., Hu, Z.Q., Okubo, S., Hara, Y. and Shimamura, T. (2001): Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents. Chemother., 45, 1737-1742.